Genvax Technologies, a startup dedicated to bringing advances in RNA vaccine production to animal health, announced it has closed its Series Seed Plus funding. This pivotal funding will accelerate the company's path toward USDA approval of its vaccines, enabling rapid response to foreign animal disease outbreaks and improving livestock health and profitability.

United Animal Health led the financing with support from Johnsonville Ventures, Iowa Farm Bureau's Rural Vitality Funds, Iowa Corn Growers Association, and members of Ag Startup Engine.